Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Integrative modelling of single-cell data to elucidate the genetic architecture of complex disease

$5.07M USD

Funder NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Recipient Organization Dana-Farber Cancer Inst
Country United States
Start Date Aug 01, 2024
End Date Apr 30, 2028
Duration 1,368 days
Number of Grantees 3
Roles Principal Investigator; Co-Investigator
Data Source NIH (US)
Grant ID 10879333
Grant Description

PROJECT SUMMARY/ABSTRACT Leveraging Genome Wide Association Studies (GWAS) to understand disease has proven challenging, as the underlying biological mechanisms are often poorly captured by bulk tissues. Recent advances in single-cell sequencing have led to a torrent of data across multiple modalities, contexts, and individuals, which provide an

unprecedented opportunity to understand disease biology at high resolution. We hypothesize that the fine-scale cellular contexts captured by single-cell data will be effective at explaining disease heritability and fine-mapping disease mechanisms. However, current approaches to integrate single-cell data with GWAS largely rely on off-

the-shelf approaches developed for bulk sequencing, which obscure the rich phenotypic diversity present in individual cells within and across canonical cell types. The sparse and highly variable nature of single-cell data has additionally posed challenges for robustly identifying single-cell quantitative trait loci (QTL). Single-cell data

continues to increase in size and complexity, emphasizing the need for scalable integrative modeling. Here, we propose a 5-year research plan to develop novel approaches for integrating single-cell data with GWAS by modeling complex cellular phenotypes not captured by existing bulk approaches. Our proposal will identify novel

disease-relevant cell states; leverage multiple single-cell modalities to fine-map disease variants and their target genes; and discover novel single-cell QTLs associated with disease. Our specific aims are: Aim 1: Leveraging single-cell epigenetic data to identify heritable components of disease; Aim 2: Leveraging single-cell data to fine-

map disease variants and their mechanisms; Aim 3: Defining the regulatory effects of disease variants using population-scale scRNA-seq. While our proposed approaches are broadly applicable to common diseases, we will benchmark them on immune-related traits and neuropsychiatric traits which we have studied extensively with

bulk datasets in published work and where we have now aggregated a large collection of relevant single-cell datasets. Our collaboration has multiple strengths: our focus on functional data integration across multiple single- cell modalities; our broad statistical and computational expertise; and our extensive, data-driven publication

record on common disease.

All Grantees

Dana-Farber Cancer Inst

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant